Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

15
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
15
Cancer Prevention02:59

Cancer Prevention

8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Epigenetic Regulation01:37

Epigenetic Regulation

3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking personalized endometrial cancer treatment: the critical role of the BBIRE biobank in sample collection and distribution.

Frontiers in molecular biosciences·2026
Same author

Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis.

ESMO real world data and digital oncology·2026
Same author

Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania region.

ESMO real world data and digital oncology·2026
Same author

Three-dimensional assessment of the malar bone implant engagement of 100 zygomatic implants: a retrospective study.

International journal of oral and maxillofacial surgery·2025
Same author

Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey.

BMC public health·2024
Same author

Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy.

Reumatismo·2024

Related Experiment Video

Updated: Feb 16, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.9K

Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer.

A Giudice1, M Montella1, M Boccellino2

  • 1Epidemiology Unit, National Cancer Institute of Naples "G. Pascale Foundation", IRCCS, 80131 Naples, Italy.

Current Molecular Medicine
|December 20, 2017
PubMed
Summary

Green tea catechins, like EGCG, show promise in treating prostate cancer by reversing epigenetic changes and modulating miRNA expression. These natural compounds may enhance chemotherapy effectiveness and reduce side effects.

Keywords:
Prostate cancercatechinsepigenetic alterations.miRNAspolyphenols

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Experiment Videos

Last Updated: Feb 16, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.9K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Prostate cancer, particularly castrate-resistant (CRPC), presents significant treatment challenges.
  • Epigenetic modifications, including DNA methylation, histone modifications, and microRNAs (miRNAs), are crucial in prostate cancer development and progression.
  • miRNAs are small non-coding RNAs that regulate gene expression, impacting cancer pathways.

Purpose of the Study:

  • To review the role of green tea catechins in modulating epigenetic alterations and miRNA expression in prostate cancer.
  • To explore the potential of green tea catechins, such as epigallocatechin gallate (EGCG), as chemopreventive and therapeutic agents.
  • To summarize evidence on the synergistic effects of green tea polyphenols (GTPs) with conventional chemotherapeutics.

Main Methods:

  • Literature review of recent studies on green tea catechins, epigenetics, and prostate cancer.
  • Analysis of research investigating EGCG's effects on DNA methylation, histone modifications, and miRNA expression.
  • Examination of studies on the combined use of GTPs and chemotherapeutic agents.

Main Results:

  • Green tea catechins, particularly EGCG, demonstrate epigenetic modulatory effects, including influencing DNA methylation and histone modifications.
  • EGCG impacts miRNA expression and targets messenger RNAs (mRNAs), contributing to the inhibition of prostate cancer cell growth.
  • Green tea polyphenols exhibit synergistic effects when combined with standard cancer chemotherapeutics, potentially reducing toxicity.

Conclusions:

  • Green tea catechins represent a promising natural strategy for prostate cancer chemoprevention and therapy due to their epigenetic and miRNA-modulating activities.
  • Combining green tea catechins with existing chemotherapeutics may enhance treatment efficacy while mitigating adverse side effects.
  • Further research into EGCG and other GTPs could lead to novel therapeutic combinations for managing prostate cancer, especially CRPC.